Valted Seq

Valted Seq is an early-stage biopharmaceutical company led by world-renowned scientists Dr. Ted Dawson and Dr. Valina Dawson from Johns Hopkins University. The company was founded on the belief that a deeper understanding of neurodegenerative pathways is essential for developing precision therapies and identifying new biomarkers for some of the most challenging neurodegenerative diseases, including Alzheimer's and Parkinson's. Valted Seq is part of the D&D Pharmatech / Neuraly family of companies, which collaborates with leading medical research institutions to advance groundbreaking healthcare innovations.